Cite
HARVARD Citation
Kumar, P. et al. (2021). Formulation development of a live attenuated human rotavirus (RV3-BB) vaccine candidate for use in low- and middle-income countries. Human vaccines & immunotherapeutics. 17 (7), pp. 2298-2310. [Online].